Trial Profile
A Trial Comparing the Pharmacokinetic and Pharmacodynamic Properties Between NN5401 and NN1250 and Between NN5401 and Insulin Aspart in Subjects With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Nov 2013
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin degludec/insulin aspart (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Aug 2010 New trial record